Search Results

Filter
  • 1-10 of  34,355 results for ""Immune Checkpoint Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors.

  • Authors : Catanzaro E; Cell Death Investigation and Therapy (CDIT) Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent University, Ghent, Belgium.

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Cellular & molecular immunology [Cell Mol Immunol] 2025 Jan; Vol. 22 (1), pp. 24-39. Date of Electronic Publication: 2024 Dec 10.Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Emerging Strategies for Local Delivery of Immune Checkpoint Inhibitors to Potentiate Cancer Immunotherapy: Current Status and Future Prospects.

  • Authors : Chen X; State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Chinese Academy of Medical Sciences Research Unit of Oral Carcinogenesis and Management, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.; Ding W

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/chemistry ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Nov 06; Vol. 16 (44), pp. 59682-59696. Date of Electronic Publication: 2024 Oct 22.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitors.

  • Authors : Laface C; Azienda Sanitaria Provinciale, Reggio Calabria (RC), Italy.; Fina E

Subjects: Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/immunology ; Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/drug therapy ; Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/Biliary Tract Neoplasms*/therapy

  • Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2024 Dec; Vol. 24 (12), pp. 1363-1374. Date of Electronic Publication: 2024 Nov 18.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach.

  • Authors : Speranza D; Medical Oncology Unit, Department of Human Pathology 'G. Barresi', University of Messina, Messina, Italy.; Santarpia M

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/administration & dosage ; Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/etiology

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Nov; Vol. 23 (11), pp. 1405-1418. Date of Electronic Publication: 2024 Jun 03.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Mechanism research of non-coding RNA in immune checkpoint inhibitors therapy.

  • Authors : Bian J; Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.; Shao R

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/pharmacology ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: Cancer science [Cancer Sci] 2024 Nov; Vol. 115 (11), pp. 3520-3531. Date of Electronic Publication: 2024 Aug 13.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

Patients' experiences of cancer immunotherapy with immune checkpoint inhibitors: A systematic review and thematic synthesis.

  • Authors : Watts T; School of Healthcare Sciences, Cardiff University, Cardiff, UK.; Roche D

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/psychology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: Journal of clinical nursing [J Clin Nurs] 2024 Aug; Vol. 33 (8), pp. 2885-2904. Date of Electronic Publication: 2024 Apr 08.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9207302 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors.

  • Authors : Yang YN; Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.; Wang LS

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/immunology ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/therapy

  • Source: World journal of gastroenterology [World J Gastroenterol] 2024 Aug 28; Vol. 30 (32), pp. 3726-3729.Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 100883448 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.

  • Authors : Abdel-Wahab N; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine; and Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Subjects: Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/adverse effects ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Expert review of clinical immunology [Expert Rev Clin Immunol] 2024 Aug; Vol. 20 (8), pp. 873-893. Date of Electronic Publication: 2024 Mar 19.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Glioblastoma and Immune Checkpoint Inhibitors: A Glance at Available Treatment Options and Future Directions.

  • Authors : Rodriguez SMB; Neurosurgical Department, Bagdasar-Arseni Clinical Emergency Hospital, 041915 Bucharest, Romania.; Tataranu LG

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/immunology ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Oct 07; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

[Atherosclerosis, cancer and immune checkpoint inhibitors].

  • Authors : Canale ML; U.O.C. Cardiologia, Ospedale Versilia, Azienda USL Toscana Nord-Ovest, Lido di Camaiore (LU).; Greco A

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/epidemiology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/etiology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/prevention & control

  • Source: Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2024 Oct; Vol. 25 (10), pp. 711-719.Publisher: Il Pensiero Scientifico Editore Country of Publication: Italy NLM ID: 101263411 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  34,355 results for ""Immune Checkpoint Inhibitors""